Loading organizations...
Cure Kids Ventures operates as a seed and early-stage investment fund dedicated to the commercialization of innovative products and services within the healthcare sector. The fund specifically targets solutions that hold potential for improving child health outcomes, spanning areas such as medical devices, pharmaceuticals, diagnostics, health information systems, and new healthcare delivery models. Its strategic investments aim to bridge the gap between groundbreaking research and real-world application.
Established in 2008, Cure Kids Ventures emerged from the Cure Kids Foundation, a prominent organization focused on funding medical research to enhance children’s lives. The foundational insight behind its creation was the recognition that promising medical research and innovations often require dedicated capital and commercialization expertise to successfully transition from concept to widespread patient benefit. This structure allows the fund to leverage the broader mission of the Cure Kids Foundation.
The fund's portfolio companies ultimately serve a broad range of patients by developing solutions for various child health challenges. Cure Kids Ventures’ vision aligns with its parent foundation's mission: to foster a healthier future for all children by providing essential early-stage capital and strategic support to transformative healthcare innovations, ensuring that scientific advancements translate into tangible improvements in pediatric care.
Cure Kids Ventures has 3 tracked investments across 3 companies. The latest tracked deal is $13.0M Pre-Series A in Kitea Health in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 10, 2025 | Kitea Health | $13.0M Pre-Series A | Icehouse Ventures | Bioshore, Karst Peak RX, Uniservices |
| Sep 14, 2023 | Avasa | $1.6M Other Equity | — | Booster Innovation Fund, Bridgewest Group, Brisbane Angels, Jacques Richter, Pacific Channel, Uniservices |
| Mar 21, 2017 | Upside Biotechnologies | $1.6M Series A | Robbie Paul | NEW Zealand Growth Capital Partners, Tuhua Ventures, University OF Auckland |